First Dose of Pfizer-BioNTech COVID-19 Vaccine Reduces Symptomatic Disease Significantly
posted 6 days
Mashup Score: 139
Contagion Live - An Israeli study finds it had an 85% effect in lowering disease 2 to 4 weeks after administration of the initial...
Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2
posted 2 weeks
Mashup Score: 2
medRxiv - One of the key questions regarding COVID19 vaccines is whether they can reduce viral shedding. To date, Israel vaccinated substantial parts of the adult...
Initial real world evidence for lower viral load of individuals who have been vaccinated by BNT162b2 | medRxiv #vaccine #biontech #pfizer evidence of decreased #transmissability #covid https://t.co/xAEsC5Q8aJ
Genetic Vaccine Development for Infectious Diseases Summit - Download the full event guide to learn more about how the agenda will help you to translate your preclinical data into the...
The #Genetic #Vaccine Development for #Infectious #Diseases Summit will overcome the translational challenges of developing mRNA, DNA & engineered viral vector-based vaccines targeting infectious diseases, with #BioNTech, #Pfizer, #Moderna & #AstraZeneca: https://t.co/C9WDO8T2ae
The first dose of the #Pfizer #BioNTech #COVID19 #vaccine is showing it reduces symptomatic disease by 85%, 2 to 4 weeks after vaccination. https://t.co/W1vojwvDL6